| 0 (0%) | 02-21 12:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 10.97 |
1-year : | 12.82 |
| Resists | First : | 9.39 |
Second : | 10.97 |
| Pivot price | 8.56  |
|||
| Supports | First : | 8.41 |
Second : | 7.8 |
| MAs | MA(5) : | 8.31 |
MA(20) : | 8.7 |
| MA(100) : | 10.21 |
MA(250) : | 12.41 |
|
| MACD | MACD : | -0.2 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 39.3 |
D(3) : | 32 |
| RSI | RSI(14): 50 |
|||
| 52-week | High : | 17.51 | Low : | 7.42 |
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ CCRN ] has closed below upper band by 47.4%. Bollinger Bands are 21.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 8.65 - 8.67 | 8.67 - 8.7 |
| Low: | 8.25 - 8.28 | 8.28 - 8.32 |
| Close: | 8.55 - 8.6 | 8.6 - 8.66 |
Fri, 20 Feb 2026
Cross Country Healthcare, Inc. (CCRN) Stock Analysis: Exploring the 18.78% Potential Upside for Investors - DirectorsTalk Interviews
Thu, 19 Feb 2026
Price-Driven Insight from (CCRN) for Rule-Based Strategy - Stock Traders Daily
Thu, 12 Feb 2026
Investors get Q4 and full-year 2025 update from Cross Country on March 4 - Stock Titan
Tue, 09 Dec 2025
Insider Purchase: Director at $CCRN Buys 200 Shares | CCRN Stock News - Quiver Quantitative
Thu, 04 Dec 2025
Cross Country Healthcare Merger Agreement with Aya Healthcare Terminated - Business Wire
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 33 (M) |
| Shares Float | 31 (M) |
| Held by Insiders | 5.3 (%) |
| Held by Institutions | 99.1 (%) |
| Shares Short | 1,260 (K) |
| Shares Short P.Month | 1,200 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 12.55 |
| Profit Margin | -1.4 % |
| Operating Margin | 0.3 % |
| Return on Assets (ttm) | 0.4 % |
| Return on Equity (ttm) | -3.8 % |
| Qtrly Rev. Growth | -20.7 % |
| Gross Profit (p.s.) | 6.94 |
| Sales Per Share | 34.49 |
| EBITDA (p.s.) | 0.63 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 54 (M) |
| Levered Free Cash Flow | 57 (M) |
| PE Ratio | -17.58 |
| PEG Ratio | 0 |
| Price to Book value | 0.68 |
| Price to Sales | 0.24 |
| Price to Cash Flow | 5.19 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|